Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Guillaume Magnin

Showing results (11-20 of 17) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 17 results.
Psycho-Oncology|September 11, 2015
Major depressive disorder, personality disorders, and coping strategies are independent risk factors for lower quality of life in non-metastatic breast cancer patientsPaul Brunault, Anne-Laure Champagne, Grégoire Huguet, et al.
Psychiatry Research|January 10, 2016
Personality disorders, but not cancer severity or treatment type, are risk factors for later generalised anxiety disorder and major depressive disorder in non metastatic breast cancer patientsAnne-Laure Champagne, Paul Brunault, Grégoire Huguet, et al.
Environmental Health Perspectives|December 19, 2009
Maternal blood lead levels and the risk of pregnancy-induced hypertension: the EDEN cohort studyChadi Yazbeck, Olivier Thiebaugeorges, Thierry Moreau, et al.
The British Journal of Nutrition|May 22, 2010
Prenatal mercury contamination: relationship with maternal seafood consumption during pregnancy and fetal growth in the 'EDEN mother-child' cohortPeggy Drouillet-Pinard, Guy Huel, R Slama, et al.
Environmental Health Perspectives|August 13, 2009
Maternal personal exposure to airborne benzene and intrauterine growthRémy Slama, Olivier Thiebaugeorges, Valérie Goua, et al.
The Oncologist|January 12, 2012
Results of the GYNECO 02 study, an FNCLCC phase III trial comparing hysterectomy with no hysterectomy in patients with a (clinical and radiological) complete response after chemoradiation therapy for stage IB2 or II cervical cancerPhilippe Morice, Philippe Rouanet, Annie Rey, et al.
Paediatric and Perinatal Epidemiology|January 19, 2010
Very preterm birth: who has access to antenatal corticosteroid therapy?Antoine Burguet, Cyril Ferdynus, Gérard Thiriez, et al.
Pageof 2

Showing results (11-20 of 17) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
Psycho-Oncology|September 11, 2015
Major depressive disorder, personality disorders, and coping strategies are independent risk factors for lower quality of life in non-metastatic breast cancer patientsPaul Brunault, Anne-Laure Champagne, Grégoire Huguet, et al.
Psychiatry Research|January 10, 2016
Personality disorders, but not cancer severity or treatment type, are risk factors for later generalised anxiety disorder and major depressive disorder in non metastatic breast cancer patientsAnne-Laure Champagne, Paul Brunault, Grégoire Huguet, et al.
Environmental Health Perspectives|December 19, 2009
Maternal blood lead levels and the risk of pregnancy-induced hypertension: the EDEN cohort studyChadi Yazbeck, Olivier Thiebaugeorges, Thierry Moreau, et al.
The British Journal of Nutrition|May 22, 2010
Prenatal mercury contamination: relationship with maternal seafood consumption during pregnancy and fetal growth in the 'EDEN mother-child' cohortPeggy Drouillet-Pinard, Guy Huel, R Slama, et al.
Environmental Health Perspectives|August 13, 2009
Maternal personal exposure to airborne benzene and intrauterine growthRémy Slama, Olivier Thiebaugeorges, Valérie Goua, et al.
The Oncologist|January 12, 2012
Results of the GYNECO 02 study, an FNCLCC phase III trial comparing hysterectomy with no hysterectomy in patients with a (clinical and radiological) complete response after chemoradiation therapy for stage IB2 or II cervical cancerPhilippe Morice, Philippe Rouanet, Annie Rey, et al.
Paediatric and Perinatal Epidemiology|January 19, 2010
Very preterm birth: who has access to antenatal corticosteroid therapy?Antoine Burguet, Cyril Ferdynus, Gérard Thiriez, et al.
Pageof 2